Clinical Research Directory
Browse clinical research sites, groups, and studies.
BRCA1/2 Flu Vaccine
Sponsor: Abramson Cancer Center at Penn Medicine
Summary
To evaluate immune function in BRCA1/2 mutation carriers without cancer, specifically to determine whether immune function in healthy individuals with germline loss of function BRCA1/2 mutations, impacts overall immune health and fitness.
Official title: Influenza Vaccine Study in BRCA1 or BRCA2 Carriers
Key Details
Gender
All
Age Range
25 Years - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2019-10-28
Completion Date
2026-06
Last Updated
2025-10-06
Healthy Volunteers
Yes
Conditions
Interventions
Seasonal influenza vaccine
To evaluate immune function in BRCA1/2 mutation carriers without cancer following seasonal influenza vaccination
Locations (1)
University of Pennsylvania
Philadelphia, Pennsylvania, United States